AC Immune SA Operating Income

AC Immune SA (ACIU) currently reports a operating income of $-61M as of March 2026. That compares with $-52M in the prior-year period — down 18.6% year over year. Use the charts on this page to explore AC Immune SA's operating income history and peer comparisons.

AC Immune SA's operating income decreased from $-52M to $-61M — a 18.6% year-over-year decrease (period ending March 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

AC Immune SA reported $-61M in operating income as of March 2026. That compares with $-52M in the prior-year period — down 18.6% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current operating income of $-61M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for AC Immune SA, and consider following ACIU for alerts when major investors trade the stock.

AC Immune SA is classified in the Healthcare sector. On operating income, it currently shows $-61M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing ACIU with unrelated industries.